Research company Hamlet Biopharma's regular subscription period for TO5B runs from July 20 to July 31, according to a press release. Approximately 5.4 million options remain, and full exercise at the exercise price of SEK 6 per share would bring the company about SEK 32 million.In April, approximately 1.5 million options were exercised early, which generated SEK 9 million.